Patents by Inventor Malcolm Cecil Pike

Malcolm Cecil Pike has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for contraception and for treatment of benign gynecological disorders
    Publication number: 20010016578
    Abstract: Compositions and methods for use in preventing conception or treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent [e.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitor] administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixtures thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premenstrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.
    Type: Application
    Filed: May 1, 2001
    Publication date: August 23, 2001
    Applicant: Balance Pharmaceuticals, Inc.
    Inventors: Darcy V. Spicer, Malcolm Cecil Pike, John R. Daniels
  • Compositions and methods for contraception and for treatment of benign gynecological disorders
    Patent number: 6225298
    Abstract: Compositions and methods for use in preventing conception or treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent [e.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitor] administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixtures thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premenstrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.
    Type: Grant
    Filed: June 18, 1997
    Date of Patent: May 1, 2001
    Assignee: Balance Pharmaceuticals, Inc.
    Inventors: Darcy V. Spicer, Malcolm Cecil Pike, John R. Daniels